Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: Treatment with mask AeroChamber

Chest

Volumn 115, Issue 1, 1999, Pages 279-282

  Newhouse, Michael T ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

AeroChamber with mask; Granulation tissue; Hemoptysis; MDI; Oleic acid; Tracheostomy

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; SALBUTAMOL;

AGED; ARTICLE; BRONCHODILATING ACTIVITY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEVICE; FIBEROPTIC BRONCHOSCOPY; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; STOMA; TRACHEOSTOMY;

EID: 0032905493     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.1.279     Document Type: Article

References (6)

1. 1 Dolovich M, Ruffin R, Corr D, Newhouse M. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 1983; 84:36-41
2. 2 Heistracher T, Balashazy I, Hofman W. The significance of secondary flow for localized particle deposition in bronchial airway bifurcations. J Aerosol Sci 1995; 26(suppl 1):S615-S616
3. 3 Spahr-Schopfer IA, Lerman J, Cutz E, et al. Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am J Respir Grit Care Med 1994; 150:790-794
4. 4 Chua HL, Chambers CB, Newhouse MT. Upper respiratory tract (URT) salbutamol (S) deposition following MDI or MDI+Aerochamber: effect of mouth rinsing on oropharyngeal clearance. J Aerosol Med 1995; 8:89
5. 5 Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol 1988; 81:424-428
6. 6 Chua HL, Chambers CB, Newhouse MT. Comparison of the effect of four MDI add-on devices on lung deposition and function in asthmatics. Am J Respir Crit Care Med 1994; 149:A217